Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Marksans Pharma Ltd.

  • NSE: MARKSANS

  • BSE: 524404

  • Q
  • V
  • T
  • Strong Performer, Getting Expensive
67.40/100

Quality Score

High Financial Strength
32.67/100

Valuation Score

Mid Valuation
71.68/100

Technical Score

Technically Bullish
Broker Average Rating

0.00

Broker Average Rating

MFI

34.96

MFI is mid-range

50Day SMA Rs

27.28 Rs

Price above SMA 27.28

Quality score

67.40

High Financial Strength

30Day SMA Rs

32.29 Rs

Price above SMA 32.29

Broker Covering stock

0.00

0 Broker Covering stock

Broker 6M Target upgrade

0.00

0 Broker 6M Target upgrade

Broker 6M Target downgrade

0.00

0 Broker 6M Target downgrade

Momentum score

71.68

Technically Bullish

Price to Book Value

2.49

Above industry median.

Broker Reports in 1Yr

0.00

0 Broker Reports in 1Yr

PE TTM Price to Earnings

11.39

Below industry median.

Broker 6M Reco upgrade

0.00

0 Broker 6M Reco upgrade

RSI

56.49

RSI is mid-range

Net Profit Qtr Cr

42.74 Cr

Above industry median.

Operating Revenues Qtr Cr

335.35 Cr

Above industry median.

MACD

1.67

MACD above Center

Valuation score

32.67

Mid Valuation

MACD Signal Line

2.30

MACD above Center

FII holding holding %

2.48 %

FII holding increased by 0.1%.

Promoter holding holding %

48.25 %

No change in Promoter holding

MF holding holding %

0.00 %

MF holding decreased by 0.03%.

Broker 6M Reco downgrade

0.00

0 Broker 6M Reco downgrade

100Day SMA Rs

22.13 Rs

Price above SMA 22.13

Institutions holding holding %

3.42 %

Institutions holding increased by 0.35%.

200Day SMA Rs

19.05 Rs

Price above SMA 19.05

NSE MARKSANS
33.90
  • 33.60 Close
  • 33.50 Open
  • 9.36 Lk Volume
Today Low/High
Low 33.15
High 34.80
52 Week Low/High
24-03-2020 9.85
24-06-2020 39.15

Peer Comparison

All values except ratios in INR(Crores)

Stock Name Current Price Rs PE TTM Price To Earnings Market Capitalization In Cr Dividend Yield 1yr % Net Profit Qtr Cr Net Profit Annual Growth YoY % Operating Revenues Qtr Cr Revenue Growth Qtr YoY Price To Book Value
Marksans Pharma Ltd. 33.6 11.38 1375.28 0.14 42.74 50.12 335.34 35.54 2.48
Sun Pharmaceutical Industries Ltd. 494.3 28.32 118597.39 1.16 494.35 30.45 8184.94 14.25 2.65
Dr. Reddy's Laboratories Ltd. 3911.75 33 65013.28 0.51 770.6 3.34 4448.89 10.4 4.63
Divi's Laboratories Ltd. 2199.94 42.42 58397.67 1.45 388.23 1.75 1389.71 9.67 8.39
Cipla Ltd. 640.6 33.38 51648.37 1.09 242.31 2.47 4376.18 -0.64 3.36
Aurobindo Pharma Ltd. 818.05 16.84 47929.54 0.36 868.3 20.44 6158.43 16.36 3.45
Torrent Pharmaceuticals Ltd. 2373 39.18 40160.65 1.34 314 134.92 1946 4.84 8.46
Lupin Ltd. 864 -143 39139.19 0.57 390.3 -144.75 3845.74 -12.73 2.83